High-Grade Squamous Intraepithelial Lesions
11
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
Laser Ablation in the Treatment of High-grade Cervical Lesions
Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSIL
Primary Cervical Cancer Screening by Self-sampling HPV Test
Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions
Clinical Evaluation of Detection of High Risk HPV in Urine
Evaluation of Thioldisulfide Balance in Cervical Preinvasive Lesions
Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL